ACUTA CAPITAL PARTNERS, LLC Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$96.8B
Holdings
28
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (28 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | OCULOCULAR THERAPEUTIX INC | 1,165,206 | $13.6B | 14.08% | |
| 2 | CDTXCIDARA THERAPEUTICS INC | 141,529 | $13.6B | 14.01% | |
| 3 | TRMLTOURMALINE BIO INC | 268,451 | $12.8B | 13.27% | |
| 4 | WHWKWHITEHAWK THERAPEUTICS INC | 3,410,402 | $6.5B | 6.70% | |
| 5 | IM8NINSMED INC | 38,592 | $5.6B | 5.74% | |
| 6 | DRUGBRIGHT MINDS BIOSCIENCES INC | 84,875 | $5.1B | 5.32% | |
| 7 | ARGXARGEN SE - ADR | 6,379 | $4.7B | 4.86% | |
| 8 | AMLXAMYLYX PHARMACEUTICALS INC | 333,258 | $4.5B | 4.68% | |
| 9 | TERNTERNS PHARMACEUTICALS INC | 502,797 | $3.8B | 3.90% | |
| 10 | JAZZJAZZ PHARMACEUTICALS PLC | 25,114 | $3.3B | 3.42% | |
| 11 | CMPXCOMPASS THERAPEUTICS INC | 840,090 | $2.9B | 3.04% | |
| 12 | PRAXPRAXIS PRECISION MEDICINES I | 49,751 | $2.6B | 2.72% | |
| 13 | SRZNSURROZEN INC | 178,415 | $2.3B | 2.38% | |
| 14 | ASNDASCENDIS PHA-ADR | 9,792 | $1.9B | 2.01% | |
| 15 | KRYSKRYSTAL BIOTECH INC | 10,573 | $1.9B | 1.93% | |
| 16 | OCSOCULIS HOLDING AG | 101,777 | $1.8B | 1.85% | |
| 17 | TSHATAYSHA GENE THERAPIES INC | 454,827 | $1.5B | 1.54% | |
| 18 | COGTCOGENT BIOSCIENCES INC | 102,907 | $1.5B | 1.53% | |
| 19 | ZYMEZYMEWORKS INC | 80,143 | $1.4B | 1.41% | |
| 20 | VSTMVERASTEM INC | 143,446 | $1.3B | 1.31% | |
| 21 | DNTHDIANTHUS THERAPEUTICS INC | 25,000 | $983.8M | 1.02% | |
| 22 | UTHUNITED THERAPEUTICS CORP | 2,296 | $962.5M | 0.99% | |
| 23 | INBXINHIBRX BIOSCIENCES INC | 16,377 | $551.6M | 0.57% | |
| 24 | FULCFULCRUM THERAPEUTICS INC | 57,141 | $525.7M | 0.54% | |
| 25 | LBRXLB PHARMACEUTICALS INC | 30,000 | $473.7M | 0.49% | |
| 26 | RVMDREVOLUTION MEDICINES INC | 8,411 | $392.8M | 0.41% | |
| 27 | UNCYUNICYCIVE THERAPEUTICS INC | 59,985 | $261.5M | 0.27% | |
| 28 | NUVB/WSNUVATION BIO INC -CW27 | 90,832 | $18.4M | 0.02% |